Category Archives: Zometa

zometa, osteoporosis drug, bisphosphonate

Zometa: Osteoporosis Drug Doesn’t Work for Breast Cancer

Zometa was designed as an osteoporosis drug, and the exclusive rights to manufacture it was almost over – the patent was expiring. Zometa is expensive for the patient, and profitable for the manufacturer; keeping the patent active for another 3 years by extending the approved use would create a highly profitable marketing miracle for the…

Continue Reading →